INCY Filing
4Filing Date: Jul 20, 2026

INCYTE CORP (INCY) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001205703-26-000021open_in_new
Total Value$0
Trades3
Insiders1

Transaction Details

CAGNONI PABLO J
President, Global Head of R&D·Direct
Grant · Acquire
Employee Stock Option (right to buy)Derivative
Shares+57.86K
Price$0.00
Total Value$0
Shares Owned After57.86K
Transaction DateJul 16, 2026
ExpiresJul 15, 2036
Footnotes ▸

The July 16, 2026 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Remarks:

CAGNONI PABLO J
President, Global Head of R&D·Direct
Grant · Acquire
Common Stock
Shares+13.40K
Price$0.00
Total Value$0
Shares Owned After231.33K
Transaction DateJul 16, 2026
Footnotes ▸

Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. | Including the July 16, 2026 grant, this includes an aggregate of 183,200 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.

CAGNONI PABLO J
President, Global Head of R&D·Direct
Grant · Acquire
Performance SharesDerivative
Shares+33.51K
Price$0.00
Total Value$0
Shares Owned After33.51K
Transaction DateJul 16, 2026
ExpiresJul 16, 2029
Footnotes ▸

Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2026 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. | Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2026 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.

Post-Transaction Holdings

CAGNONI PABLO J
SecuritySharesChange
Common Stock231.33K+13.40K (6.15%)
Employee Stock Option (right to buy)57.86K+57.86K
Performance Shares33.51K+33.51K
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-07-16 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: INCYTE CORP (INCY) CIK: 0000879169 --- Reporting Owner --- Name: CAGNONI PABLO J CIK: 0001205703 Role: Officer (President, Global Head of R&D) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-07-16 | Code: A (Grant or award) Shares: +13,403 | Price: $0.00 Shares Owned After: 231,332 | Ownership: D (Direct) Footnotes: [F1] Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. [F2] Including the July 16, 2026 grant, this includes an aggregate of 183,200 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. --- Derivative Transactions --- [Transaction #1] Security: Performance Shares Date: 2026-07-16 | Code: A (Grant or award) Shares: +33,508 | Price: $0.00 Exercisable: N/A | Expires: 2029-07-16 Shares Owned After: 33,508 | Ownership: D (Direct) Footnotes: [F3] Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2026 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. [F3] Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2026 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. [Transaction #2] Security: Employee Stock Option (right to buy) Date: 2026-07-16 | Code: A (Grant or award) Shares: +57,861 | Price: $0.00 Exercisable: N/A | Expires: 2036-07-15 Shares Owned After: 57,861 | Ownership: D (Direct) Footnotes: [F4] The July 16, 2026 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Remarks: --- Footnotes (Complete Index) --- F1: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis. F2: Including the July 16, 2026 grant, this includes an aggregate of 183,200 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. F3: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2026 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer. F4: The July 16, 2026 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Remarks: --- Signature --- /s/ /s/ Elizabeth Feeney, Attorney-In-Fact (2026-07-20)

keid analysis is for reference only and does not constitute investment advice.